Standout Papers

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2003 2026 2010 2018 933
  1. A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis (2003)
    David H. Miller, Omar Khan et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 26 from Science/Nature 80 standout
Sub-graph 1 of 19

Citing Papers

Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
14 intermediate papers

Works of Lance D. Blumhardt being referenced

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2003 Standout

Author Peers

Author Last Decade Papers Cites
Lance D. Blumhardt 1194 901 475 476 50 3.2k
Nancy L. Sicotte 1363 1605 449 555 75 5.2k
Valentina Tomassini 1849 1495 853 399 87 4.5k
Yves Lapierre 1836 329 708 471 58 3.8k
Fritz Leutmezer 1132 540 745 915 124 3.0k
Alan Coulthard 1086 333 570 218 122 3.8k
Myriam Schluep 1215 432 1086 164 90 3.7k
Dorothea Buck 1135 242 433 274 39 2.4k
Sven Ekholm 770 826 872 417 146 5.3k
Ernst W. Radue 2179 382 966 233 65 4.3k
Maria Ban 924 356 1213 297 48 3.4k

All Works

Loading papers...

Rankless by CCL
2026